AUSTIN, Texas, March 03, 2020 -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it will.
Chembio Diagnostics, Inc. (CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced President and Chief Executive Officer John Sperzel has resigned for another opportunity. The Chembio Board of Directors has appointed Director Gail Page as Interim CEO and initiated an executive search process to identify a permanent CEO. Gail Page has served on the Chembio Board of Directors since 2017.
Vermillion, Inc. (VRML) today announced its wholly owned subsidiary, ASPiRA LABS, is now credentialed with Florida’s State Medicaid program for an estimated additional 3.6 million credentialed Medicaid lives. Florida has the fourth largest state Medicaid populations in the U.S. and ASPiRA is now credentialed in 4 of the top 5 states by Medicaid population size, including California, Pennsylvania, Texas and now Florida.
Q3 2019 Vermillion Inc Earnings Call
Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by more than 10 percentage points since the end of the third quarter of 2018 as investors first worried over the possible ramifications of rising interest rates and the escalation of the trade war with China. The hedge funds and institutional investors we track […]
Conference Call scheduled for today, March 26th at 4:30 p.m. ET AUSTIN, Texas, March 26, 2020 -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical based women’s health company.
AUSTIN, Texas, Jan. 02, 2020 -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that management.
AUSTIN, Texas, Feb. 25, 2020 -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that management.
AUSTIN, Texas, May 14, 2020 -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial.
AUSTIN, Texas, Nov. 21, 2019 -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that management.
Valerie Palmieri has been the CEO of Vermillion, Inc. (NASDAQ:VRML) since 2015. First, this article will compare CEO...
It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...
NEW YORK, NY / ACCESSWIRE / March 26, 2020 / Vermillion, Inc. (NASDAQ:VRML) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 26, 2020 at 4:30 PM ...
AUSTIN, Texas, March 27, 2020 -- Vermillion, Inc. (NASDAQ: VRML), a bioinformatics-based women’s health company focused on gynecologic disease, announced yesterday that its.
Q1 2020 Vermillion Inc Earnings Call
AUSTIN, Texas, April 30, 2020 -- Vermillion, Inc. (Nasdaq: VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced that it will.
Vermillion, Inc. (VRML), a bioanalytical-based women’s health company focused on gynecologic disease, today announced Valerie Palmieri will participate on a Women in Leadership Panel, representing the corporate sector, at “Women and Girls Day” at the Connecticut State Capital. The all-day event is in celebration of Women’s History Month and the 100th anniversary of women’s suffrage. The company will also have an education booth on site for OVA1 Plus and overall Ovarian Cancer Awareness.
Q4 2019 Vermillion Inc Earnings Call
AUSTIN, Texas, Nov. 12, 2019 -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial.
AUSTIN, TX / ACCESSWIRE / October 15, 2019 / The MicroCap Rodeo's inaugural event is set for October 15, and 16 th , 2019 in Austin Texas at the Hilton downtown Austin. Focused on the best ideas concept, ...